Abstract

Objectives: To compare the short term clinical and biological effects of intravenous (IV) pulse methylprednisolone (MP) and infliximab (IFX) in patients with severe active rheumatoid arthritis (RA) despite methotrexate (MTX)...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis
Suqing Xu ... Fen Li
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences | VOL. 42
Suqing Xu, et. al.Suqing Xu ... Fen Li
28 Oct 2017
FRI0023 Is Positivity of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Associated with the Response Rate of Infliximab, Tocilizumab, and Abatacept in Treatment of Rheumatoid Arthritis?
M Sato ... K Saito
Annals of the Rheumatic Diseases | VOL. 73
M Sato, et. al.M Sato ... K Saito
01 Jun 2014
P622 Comparison of long-term outcomes of infliximab and adalimumab in biologic-naïve patients with ulcerative colitis
M B Durak ... I Yüksel
Journal of Crohn's and Colitis | VOL. 16
M B Durak, et. al.M B Durak ... I Yüksel
21 Jan 2022
Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
Tatyana Valentinovna Mezenova ... S Yu Davidyan
Rheumatology Science and Practice | VOL. 0
Tatyana Valentinovna Mezenova, et. al.Tatyana Valentinovna Mezenova ... S Yu Davidyan
15 Apr 2012
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
Markus Kieler ... Stephan Blüml
Annals of the Rheumatic Diseases | VOL. -
Markus Kieler, et. al.Markus Kieler ... Stephan Blüml
10 Jul 2024
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
Markus Kieler ... Stephan Blüml
Annals of the Rheumatic Diseases | VOL. -
Markus Kieler, et. al.Markus Kieler ... Stephan Blüml
10 Jul 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
Matthew A Brown ... Irene Van Der Horst-Bruinsma
Annals of the Rheumatic Diseases | VOL. -
Matthew A Brown, et. al.Matthew A Brown ... Irene Van Der Horst-Bruinsma
08 Jul 2024
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
Yusuke Yoshimura ... Naoki Sawa
Annals of the Rheumatic Diseases | VOL. -
Yusuke Yoshimura, et. al.Yusuke Yoshimura ... Naoki Sawa
04 Jul 2024
View more papers